Page last updated: 2024-11-03

propentofylline and Cognition Disorders

propentofylline has been researched along with Cognition Disorders in 2 studies

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
"In experimental models of vascular dementia and/or Alzheimer's disease it improves cognitive functions, inhibits inflammatory processes as well as excessive activation of microglia, formation of free radicals, cytocines and abnormal amyloid precursor proteins (APP)."2.40[New pharmacologic aspects in the neurologic profile of propentofylline (Karsivan ad us. vet.)]. ( Kapl, D; Rudolphi, KA, 1998)
"Propentofylline has potent stimulatory effects on NGF synthesis/secretion in mouse astrocytes in vitro."1.29Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum. ( Furukawa, S; Hasegawa, T; Nabeshima, T; Nitta, A; Ogihara, Y; Onishi, J, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nitta, A1
Ogihara, Y1
Onishi, J1
Hasegawa, T1
Furukawa, S1
Nabeshima, T1
Kapl, D1
Rudolphi, KA1

Reviews

1 review available for propentofylline and Cognition Disorders

ArticleYear
[New pharmacologic aspects in the neurologic profile of propentofylline (Karsivan ad us. vet.)].
    Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere, 1998, Volume: 26, Issue:5

    Topics: Adenosine; Alzheimer Disease; Animals; Cerebrovascular Circulation; Cognition Disorders; Dementia, V

1998

Other Studies

1 other study available for propentofylline and Cognition Disorders

ArticleYear
Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum.
    European journal of pharmacology, 1996, Jun-20, Volume: 307, Issue:1

    Topics: Administration, Intranasal; Animals; Anti-Ulcer Agents; Antibodies, Monoclonal; Choline O-Acetyltran

1996